Quarterly report pursuant to Section 13 or 15(d)

BUSINESS (Details Narrative)

v3.21.2
BUSINESS (Details Narrative)
1 Months Ended
Jul. 28, 2016
BioCorRx Pharmaceuticals [Member]  
Equity issued ownership 75.8
Non-Controlling Interest [Member]  
Equity issued ownership 24.